Software Healthcare Sector

KALA BIO

Market Cap: US$15.4m

A biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States.

KDA Group

Market Cap: CA$21.2m

Provides technological and operational efficiency solutions for both the general and specialized health sectors in Canada.

Longduoduo

Market Cap: US$15.3m

Together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China.

Alzai Health

Market Cap: CA$21.2m

A healthcare technology company, provides artificial intelligence driven solution for risk screening.

BLIS Technologies

Market Cap: NZ$25.6m

Develops and sells probiotics in New Zealand, the Asia Pacific, Europe, the Middle East, Africa, and North America.

Psychemedics

Market Cap: US$15.2m

Engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally.

Conavi Medical

Market Cap: CA$21.0m

Focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures.

Avem Health Partners

Market Cap: US$15.2m

Provides financial, technology, management, and capital solutions to hospitals in rural markets.

Intelicare Holdings

Market Cap: AU$20.7m

Engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia.

Patrys

Market Cap: AU$20.7m

Develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases.

Vitura Health

Market Cap: AU$20.5m

Engages in the sale and distribution of medicinal cannabis products in Australia.

Kun Peng International

Market Cap: US$14.6m

Engages in the distribution of health care and health-related household products through its online platforms in the People’s Republic of China.

Akari Therapeutics

Market Cap: US$14.5m

An oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins.

Passage Bio

Market Cap: US$14.5m

A genetic medicines company, develops gene therapies for central nervous system diseases.

Bionano Genomics

Market Cap: US$14.4m

Provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia.

Protect Pharmaceutical

Market Cap: US$14.4m

Primarily focuses on crop farming and agricultural businesses.

Peak Processing

Market Cap: AU$19.9m

Manufactures, distributes, and sells recreational cannabis products in Canada and the United States.

Adial Pharmaceuticals

Market Cap: US$14.2m

A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.

SeaStar Medical Holding

Market Cap: US$14.1m

A commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.

Avicanna

Market Cap: CA$19.3m

A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally.

Syra Health

Market Cap: US$13.9m

A healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education and training, and healthcare workforce development and staffing in the United States.

Micro-X

Market Cap: AU$19.4m

Designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology.

PainChek

Market Cap: AU$19.4m

Develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally.

NeuroSense Therapeutics

Market Cap: US$13.9m

A clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally.

Synlogic

Market Cap: US$13.8m

Does not have significant operations.

GT Biopharma

Market Cap: US$13.8m

A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) platforms.

BCAL Diagnostics

Market Cap: AU$19.2m

A screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.

Phio Pharmaceuticals

Market Cap: US$13.6m

A clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States.

Bio Essence

Market Cap: US$13.5m

Engages in manufacturing and distributing health supplement products.

Advanced Biomed

Market Cap: US$13.3m

An investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan.

Memphasys

Market Cap: AU$18.5m

Develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.

Ventripoint Diagnostics

Market Cap: CA$18.1m

A medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide.

IRIDEX

Market Cap: US$13.1m

An ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.

ImpediMed

Market Cap: AU$18.3m

A medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally.

Adagio Medical Holdings

Market Cap: US$13.1m

A medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.

Nanalysis Scientific

Market Cap: CA$18.1m

Develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally.